Management strategies for osteoporosis and osteopenia
A 60-year-old woman came into our office for her annual examination. We noted that she had lost 1.5 inches in height.
A 60-year-old woman came into our office for her annual examination. We noted that she had lost 1.5 inches in height. We secured an immediate appointment with the dual-energy x-ray absorptiometry (DXA) technician. The result was a T-score of –1.5 (low bone mass, osteopenia). The questions were: How to treat her condition? Was a prescription therapy needed? Which therapy (eg, bisphosphonate, selective estrogen-receptor modular [SERM], or parathyroid hormone [PTH]) was most appropriate? How should she be treated in light of the many complications from long-term therapy?
Eventually, our dilemma would be how to treat this woman without overtreating her. To make an appropriate decision about whether and how to treat her, associated information must be gathered, including history and laboratory results. Evaluation guidelines are followed by discussion of 3 different scenarios.
History
Laboratory workup
These tests should be ordered:
Low creatinine-to-cystatin C ratio linked to postmenopausal muscle loss
March 20th 2025A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.
Read More
